Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review.

Copson E, Shaaban AM, Maishman T, Moseley PM, McKenzie H, Bradbury J, Borley A, Brzezinska M, Chan SYT, Ching J, Cutress RI, Danial I, Dall B, Kerin M, Lowery AJ, Macpherson IR, Romics L, Sawyer E, Sharmat N, Sircar T, Vidya R, Pan Y, Rea D, Jones L, Eccles DM, Berditchevski F.

Breast. 2018 Dec;42:133-141. doi: 10.1016/j.breast.2018.09.003. Epub 2018 Sep 15.

PMID:
30278369
2.

CD151 regulates expression of FGFR2 in breast cancer cells via PKC-dependent pathways.

Sadej R, Lu X, Turczyk L, Novitskaya V, Lopez-Clavijo AF, Kordek R, Potemski P, Wakelam MJO, Romanska-Knight H, Berditchevski F.

J Cell Sci. 2018 Oct 29;131(21). pii: jcs220640. doi: 10.1242/jcs.220640.

3.

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.

Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, El-Zein R, Rahal OM, Alexander A, Reuben JM, Krishnamurthy S, Lucci A, Ueno NT.

J Cancer. 2017 Oct 9;8(17):3607-3614. doi: 10.7150/jca.21200. eCollection 2017.

4.

CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma.

Wadkin JCR, Patten DA, Kamarajah SK, Shepherd EL, Novitskaya V, Berditchevski F, Adams DH, Weston CJ, Shetty S.

Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G138-G149. doi: 10.1152/ajpgi.00411.2016. Epub 2017 May 4.

5.

Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments.

Guix FX, Sannerud R, Berditchevski F, Arranz AM, Horré K, Snellinx A, Thathiah A, Saido T, Saito T, Rajesh S, Overduin M, Kumar-Singh S, Radaelli E, Corthout N, Colombelli J, Tosi S, Munck S, Salas IH, Annaert W, De Strooper B.

Mol Neurodegener. 2017 Mar 10;12(1):25. doi: 10.1186/s13024-017-0165-0.

6.

Differential regulation of cellular functions by the C-termini of transmembrane 4 L six family proteins in 2- or 3-dimensional environment.

Cheong JG, Song DG, Song HE, Berditchevski F, Nam SH, Jung JW, Kim HJ, Kim JE, Kim S, Ryu J, Cho CY, Lee KM, Lee JW.

Oncotarget. 2017 Feb 21;8(8):13277-13292. doi: 10.18632/oncotarget.14809.

7.

Tetraspanin Tspan9 regulates platelet collagen receptor GPVI lateral diffusion and activation.

Haining EJ, Matthews AL, Noy PJ, Romanska HM, Harris HJ, Pike J, Morowski M, Gavin RL, Yang J, Milhiet PE, Berditchevski F, Nieswandt B, Poulter NS, Watson SP, Tomlinson MG.

Platelets. 2017 Nov;28(7):629-642. doi: 10.1080/09537104.2016.1254175. Epub 2016 Dec 29.

8.

The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses.

Gräßel L, Fast LA, Scheffer KD, Boukhallouk F, Spoden GA, Tenzer S, Boller K, Bago R, Rajesh S, Overduin M, Berditchevski F, Florin L.

Sci Rep. 2016 Aug 31;6:32337. doi: 10.1038/srep32337.

9.

ErbB receptors and tetraspanins: Casting the net wider.

Berditchevski F, Odintsova E.

Int J Biochem Cell Biol. 2016 Aug;77(Pt A):68-71. doi: 10.1016/j.biocel.2016.05.017. Epub 2016 Jun 1. Review. No abstract available.

PMID:
27262234
10.

Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.

Marcus EA, Tokhtaeva E, Turdikulova S, Capri J, Whitelegge JP, Scott DR, Sachs G, Berditchevski F, Vagin O.

Biochem J. 2016 Jun 15;473(12):1703-18. doi: 10.1042/BCJ20160203. Epub 2016 Apr 5.

11.

Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.

Romanska HM, Potemski P, Krakowska M, Mieszkowska M, Chaudhri S, Kordek R, Kubiak R, Speirs V, Hanby AM, Sadej R, Berditchevski F.

Br J Cancer. 2015 Nov 3;113(9):1350-7. doi: 10.1038/bjc.2015.344. Epub 2015 Sep 29.

12.

Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studies.

Nash CE, Mavria G, Baxter EW, Holliday DL, Tomlinson DC, Treanor D, Novitskaya V, Berditchevski F, Hanby AM, Speirs V.

Oncotarget. 2015 May 30;6(15):13731-41.

13.

Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research.

Rea D, Francis A, Hanby AM, Speirs V, Rakha E, Shaaban A, Chan S, Vinnicombe S, Ellis IO, Martin SG, Jones LJ, Berditchevski F; UK Inflammatory Breast Cancer Working group.

Br J Cancer. 2015 Apr 28;112(9):1613-5. doi: 10.1038/bjc.2015.115. Epub 2015 Mar 31. No abstract available.

14.

The tetraspanin CD151 in papillomavirus infection.

Scheffer KD, Berditchevski F, Florin L.

Viruses. 2014 Feb 18;6(2):893-908. doi: 10.3390/v6020893. Review.

15.

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJ, Cox A, Curtin NJ, Dekker LV, Silva Idos S, Duffy SW, Easton DF, Eccles DM, Edwards DR, Edwards J, Evans D, Fenlon DF, Flanagan JM, Foster C, Gallagher WM, Garcia-Closas M, Gee JM, Gescher AJ, Goh V, Groves AM, Harvey AJ, Harvie M, Hennessy BT, Hiscox S, Holen I, Howell SJ, Howell A, Hubbard G, Hulbert-Williams N, Hunter MS, Jasani B, Jones LJ, Key TJ, Kirwan CC, Kong A, Kunkler IH, Langdon SP, Leach MO, Mann DJ, Marshall JF, Martin L, Martin SG, Macdougall JE, Miles DW, Miller WR, Morris JR, Moss SM, Mullan P, Natrajan R, O'Connor JP, O'Connor R, Palmieri C, Pharoah PD, Rakha EA, Reed E, Robinson SP, Sahai E, Saxton JM, Schmid P, Smalley MJ, Speirs V, Stein R, Stingl J, Streuli CH, Tutt AN, Velikova G, Walker RA, Watson CJ, Williams KJ, Young LS, Thompson AM.

Breast Cancer Res. 2013 Oct 1;15(5):R92. doi: 10.1186/bcr3493. Review.

16.

Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.

Odintsova E, van Niel G, Conjeaud H, Raposo G, Iwamoto R, Mekada E, Berditchevski F.

J Biol Chem. 2013 Sep 6;288(36):26323-34. doi: 10.1074/jbc.M112.439380. Epub 2013 Jul 29.

17.

Integrin α3β1-CD151 complex regulates dimerization of ErbB2 via RhoA.

Novitskaya V, Romanska H, Kordek R, Potemski P, Kusińska R, Parsons M, Odintsova E, Berditchevski F.

Oncogene. 2014 May 22;33(21):2779-89. doi: 10.1038/onc.2013.231. Epub 2013 Jun 24.

PMID:
23792450
18.

Tetraspanin CD151 mediates papillomavirus type 16 endocytosis.

Scheffer KD, Gawlitza A, Spoden GA, Zhang XA, Lambert C, Berditchevski F, Florin L.

J Virol. 2013 Mar;87(6):3435-46. doi: 10.1128/JVI.02906-12. Epub 2013 Jan 9.

19.

Loss of CD151/Tspan24 from the complex with integrin α3β1 in invasive front of the tumour is a negative predictor of disease-free survival in oral squamous cell carcinoma.

Romanska HM, Potemski P, Collins SI, Williams H, Parmar S, Berditchevski F.

Oral Oncol. 2013 Mar;49(3):224-9. doi: 10.1016/j.oraloncology.2012.09.013. Epub 2012 Oct 23.

PMID:
23099281
20.

α3β1 integrins regulate CD151 complex assembly and membrane dynamics in carcinoma cells within 3D environments.

Scales TM, Jayo A, Obara B, Holt MR, Hotchin NA, Berditchevski F, Parsons M.

Oncogene. 2013 Aug 22;32(34):3965-79. doi: 10.1038/onc.2012.415. Epub 2012 Sep 17.

PMID:
22986527
21.

Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81.

Rajesh S, Sridhar P, Tews BA, Fénéant L, Cocquerel L, Ward DG, Berditchevski F, Overduin M.

J Virol. 2012 Sep;86(18):9606-16. doi: 10.1128/JVI.00559-12. Epub 2012 Jun 27.

22.

Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology.

Turner AM, McGowan L, Millen A, Rajesh P, Webster C, Langman G, Rock G, Tachibana I, Tomlinson MG, Berditchevski F, Naidu B.

Eur Respir J. 2013 Feb;41(2):410-6. doi: 10.1183/09031936.00002912. Epub 2012 May 3.

23.

Binding to syntenin-1 protein defines a new mode of ubiquitin-based interactions regulated by phosphorylation.

Rajesh S, Bago R, Odintsova E, Muratov G, Baldwin G, Sridhar P, Rajesh S, Overduin M, Berditchevski F.

J Biol Chem. 2011 Nov 11;286(45):39606-14. doi: 10.1074/jbc.M111.262402. Epub 2011 Sep 26.

24.

The role of tetraspanin CD63 in antigen presentation via MHC class II.

Petersen SH, Odintsova E, Haigh TA, Rickinson AB, Taylor GS, Berditchevski F.

Eur J Immunol. 2011 Sep;41(9):2556-61. doi: 10.1002/eji.201141438. Epub 2011 Aug 4.

25.

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer.

Voss MA, Gordon N, Maloney S, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Berditchevski F, Sundar S.

Br J Cancer. 2011 May 10;104(10):1611-8. doi: 10.1038/bjc.2011.80. Epub 2011 Apr 19.

26.

The effect of cell-ECM adhesion on signalling via the ErbB family of growth factor receptors.

Alexi X, Berditchevski F, Odintsova E.

Biochem Soc Trans. 2011 Apr;39(2):568-73. doi: 10.1042/BST0390568. Review.

PMID:
21428941
27.

Tetraspanin CD9 in cell migration.

Powner D, Kopp PM, Monkley SJ, Critchley DR, Berditchevski F.

Biochem Soc Trans. 2011 Apr;39(2):563-7. doi: 10.1042/BST0390563. Review.

PMID:
21428940
28.

Tetraspanins in human epithelial malignancies.

Romanska HM, Berditchevski F.

J Pathol. 2011 Jan;223(1):4-14. doi: 10.1002/path.2779. Epub 2010 Oct 11. Review.

PMID:
20938929
29.

Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells.

Mitchell K, Svenson KB, Longmate WM, Gkirtzimanaki K, Sadej R, Wang X, Zhao J, Eliopoulos AG, Berditchevski F, Dipersio CM.

Cancer Res. 2010 Aug 1;70(15):6359-67. doi: 10.1158/0008-5472.CAN-09-4283. Epub 2010 Jul 14.

30.

Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis.

Sadej R, Romanska H, Kavanagh D, Baldwin G, Takahashi T, Kalia N, Berditchevski F.

Cancer Res. 2010 Jul 15;70(14):6059-70. doi: 10.1158/0008-5472.CAN-09-3497. Epub 2010 Jun 22.

31.

Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ.

Novitskaya V, Romanska H, Dawoud M, Jones JL, Berditchevski F.

Cancer Res. 2010 Jun 1;70(11):4698-708. doi: 10.1158/0008-5472.CAN-09-4330. Epub 2010 May 25.

32.

CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium.

Sadej R, Romanska H, Baldwin G, Gkirtzimanaki K, Novitskaya V, Filer AD, Krcova Z, Kusinska R, Ehrmann J, Buckley CD, Kordek R, Potemski P, Eliopoulos AG, Lalani el-N, Berditchevski F.

Mol Cancer Res. 2009 Jun;7(6):787-98. doi: 10.1158/1541-7786.MCR-08-0574. Epub 2009 Jun 16.

33.

Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin.

Baldwin G, Novitskaya V, Sadej R, Pochec E, Litynska A, Hartmann C, Williams J, Ashman L, Eble JA, Berditchevski F.

J Biol Chem. 2008 Dec 19;283(51):35445-54. doi: 10.1074/jbc.M806394200. Epub 2008 Oct 13.

34.

Identification of Tspan9 as a novel platelet tetraspanin and the collagen receptor GPVI as a component of tetraspanin microdomains.

Protty MB, Watkins NA, Colombo D, Thomas SG, Heath VL, Herbert JM, Bicknell R, Senis YA, Ashman LK, Berditchevski F, Ouwehand WH, Watson SP, Tomlinson MG.

Biochem J. 2009 Jan 1;417(1):391-400. doi: 10.1042/BJ20081126.

35.

The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility.

Lekishvili T, Fromm E, Mujoomdar M, Berditchevski F.

J Cell Sci. 2008 Mar 1;121(Pt 5):685-94. doi: 10.1242/jcs.020347. Epub 2008 Feb 12.

36.

Tetraspanins as regulators of protein trafficking.

Berditchevski F, Odintsova E.

Traffic. 2007 Feb;8(2):89-96. Epub 2006 Dec 20. Review.

37.

Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.

Mejlvang J, Kriajevska M, Berditchevski F, Bronstein I, Lukanidin EM, Pringle JH, Mellon JK, Tulchinsky EM.

Exp Cell Res. 2007 Jan 15;313(2):380-93. Epub 2006 Oct 26.

PMID:
17141758
38.

Syntenin-1 is a new component of tetraspanin-enriched microdomains: mechanisms and consequences of the interaction of syntenin-1 with CD63.

Latysheva N, Muratov G, Rajesh S, Padgett M, Hotchin NA, Overduin M, Berditchevski F.

Mol Cell Biol. 2006 Oct;26(20):7707-18. Epub 2006 Aug 14.

39.

Gangliosides play an important role in the organization of CD82-enriched microdomains.

Odintsova E, Butters TD, Monti E, Sprong H, van Meer G, Berditchevski F.

Biochem J. 2006 Dec 1;400(2):315-25.

40.

Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor.

Minogue S, Waugh MG, De Matteis MA, Stephens DJ, Berditchevski F, Hsuan JJ.

J Cell Sci. 2006 Feb 1;119(Pt 3):571-81.

41.

Lipid and peptide control of phosphatidylinositol 4-kinase IIalpha activity on Golgi-endosomal Rafts.

Waugh MG, Minogue S, Chotai D, Berditchevski F, Hsuan JJ.

J Biol Chem. 2006 Feb 17;281(7):3757-63. Epub 2005 Oct 25.

42.

Regulation of urokinase receptor proteolytic function by the tetraspanin CD82.

Bass R, Werner F, Odintsova E, Sugiura T, Berditchevski F, Ellis V.

J Biol Chem. 2005 Apr 15;280(15):14811-8. Epub 2005 Jan 27.

43.

Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR.

Odintsova E, Voortman J, Gilbert E, Berditchevski F.

J Cell Sci. 2003 Nov 15;116(Pt 22):4557-66.

44.

The tetraspanin CD151 functions as a negative regulator in the adhesion-dependent activation of Ras.

Sawada S, Yoshimoto M, Odintsova E, Hotchin NA, Berditchevski F.

J Biol Chem. 2003 Jul 18;278(29):26323-6. Epub 2003 Jun 2.

45.
46.

Purification of integrins and characterization of integrin-associated proteins.

Eble JA, Berditchevski F.

Methods Cell Biol. 2002;69:223-46. No abstract available.

PMID:
12070995
47.

Complexes of tetraspanins with integrins: more than meets the eye.

Berditchevski F.

J Cell Sci. 2001 Dec;114(Pt 23):4143-51. Review.

48.

Beta1 integrins show specific association with CD98 protein in low density membranes.

Kolesnikova TV, Mannion BA, Berditchevski F, Hemler ME.

BMC Biochem. 2001;2:10. Epub 2001 Oct 15.

49.

Analysis of the CD151-alpha3beta1 integrin and CD151-tetraspanin interactions by mutagenesis.

Berditchevski F, Gilbert E, Griffiths MR, Fitter S, Ashman L, Jenner SJ.

J Biol Chem. 2001 Nov 2;276(44):41165-74. Epub 2001 Jul 30.

50.

Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1.

Odintsova E, Sugiura T, Berditchevski F.

Curr Biol. 2000 Aug 24;10(16):1009-12.

Supplemental Content

Loading ...
Support Center